Amarin has entered into an exclusive marketing and commercialisation agreement with Neopharm for VAZKEPA in the State of Israel, Gaza, West Bank and the territories of the Palestinian Authority.
09 Aug 2023
18 Jul 2023
Eleven Therapeutics has entered into a research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics.
03 May 2023
Clinical-stage biotechnology company Tenaya Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its gene therapy product candidate, TN-201.
03 Apr 2023
Novartis has received positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), which recommended approval for the company’s Entresto (sacubitril/valsartan) to treat paediatric heart failure.
08 Feb 2023
The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to Rocket Pharmaceuticals’ RP-A501, an investigational adeno-associated virus (AAV)-based gene therapy to treat Danon Disease.
06 Dec 2021
Biopharmaceutical company Quantum Genomics has signed an exclusive license and production agreement with Julphar to market and manufacture firibastat.
01 Oct 2021
Merck (MSD) has agreed to acquire all the outstanding shares of Acceleron Pharma for $11.5bn in cash.
11 Feb 2021
Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine manufacturing capability.